News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Two Pharma JVs Start Operations in China: Hisun-Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK)-Simcere Pharmaceutical Group



9/14/2012 9:44:21 AM

by Richard Daverman, PhD

September 13, 2012 -- Two high-visibility generic drug JVs between east and west pharmas have commenced operations in China. Hisun Pharma and Pfizer have established their $295 million JV to produce branded generic drugs. At the same time, Merck and Simcere teamed up to concentrate on generic drugs for chronic ailments, especially cardiovascular and metabolic disease. Both were announced as letters of intent just over a year ago, and now they have become operational. More details....

Stock Symbols: (SHE: 600267) (NYSE: PFE) (NYSE: MRK) (NYSE SCR)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES